Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-07-02 16:45:54 ET · period of report 2026-06-30 · accession 0001159036-26-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-02 16:45 | 2026-06-30 | HALO | RAMSAY DAVID A | EVP, Pres, DRUG DELIVERY | M - OptEx | $0.00 | +10.0K | 10.0K | New | $0 |
| D | 2026-07-02 16:45 | 2026-06-30 | HALO | RAMSAY DAVID A | EVP, Pres, DRUG DELIVERY | F - Tax | $78.27 | -5,408 | 4,592 | -54% | -$423.3K |
| D | 2026-07-02 16:45 | 2026-06-30 | HALO | RAMSAY DAVID A | EVP, Pres, DRUG DELIVERY | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
| DM | 2026-07-02 16:45 | 2026-07-01 | HALO | RAMSAY DAVID A | EVP, Pres, DRUG DELIVERY | A - Grant | $0.00 | +56.1K | 39.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | M | A | 10,000 | $0.00 | 10,000 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-30 | F | D | 5,408 | $78.27 | 4,592 | D | — | — | (F1) The reported disposition of 5,408 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Derivative | Restricted Stock Units | 2026-06-30 | M | D | 10,000 | $0.00 | 0 | D | $0.00 · — to — | 10,000 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. The shares received upon vesting remain subject to a one-year holding period from the vesting date. (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. The shares received upon vesting remain subject to a one-year holding period from the vesting date. |
| 4 | Derivative | Restricted Stock Units | 2026-07-01 | A | A | 16,232 | $0.00 | 16,232 | D | $0.00 · 2027-07-01 to — | 16,232 Common Stock | (F3) This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. (F3) This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. |
| 5 | Derivative | Option to Purchase Common Stock | 2026-07-01 | A | A | 39,823 | $0.00 | 39,823 | D | $77.01 · 2027-07-01 to 2036-07-01 | 39,823 Common Stock | (F4) This option vests one-fourth on such date and then 1/48th monthly thereafter. |